Skip to main content
Log in

UroLift®

Ein operatives, nicht ablatives Verfahren zur Therapie des benignen Prostatasyndroms

UroLift®

An operative non-ablative procedure for treatment of benign prostatic syndrome

  • Leitthema
  • Published:
Der Urologe Aims and scope Submit manuscript

Zusammenfassung

Die Implantation von Geweberetraktoren (UroLift®, Hersteller: Neotract, USA) ermöglicht erstmalig als nicht ablative operative Technik eine moderate Deobstruktion, ohne Prostatagewebe zu entfernen oder zu destruieren. Die erzielbaren Behandlungsergebnisse gleichen mindestens denen der medikamentösen Therapie hinsichtlich der Linderung von Leidensdruck und Symptomatik (primäre Behandlungsziele) und übertreffen diese hinsichtlich Deobstruktion. Vorteil dieser Methode gegenüber allen anderen konservativen und operativen Therapieverfahren ist der Erhalt der Sexualfunktion. Derzeit erfolgt die Evaluation dieser Methode in prospektiv randomisierten Studien im Vergleich zur TUR-P (BPH-6-Studie), deren Ergebnisse für 2015 erwartet werden.

Abstract

The implantation of a tissue retractor (UroLift®, Neotract, Pleasanton, CA) allows for the first time as a non-ablative operative technique, moderate deobstruction without removal or destruction of prostate tissue. The achievable treatment results are at least comparable to drug therapy with respect to alleviation of suffering and symptoms (primary treatment aim) and superior with respect deobstruction. The advantage of this method compared to all other conservative and operative therapy procedures is preservation of sexual function. An evaluation of this method is currently being carried out and compared to TURP in prospective, randomized studies (BPH6 study) and the results are expected in 2015.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Berges R, Dreikorn K, Hofner K et al (2009) Therapy of benign prostate syndrome (BPS): guidelines of the German Urologists (DGU). Urologe A 48(12):1503–1516

    Article  PubMed  CAS  Google Scholar 

  2. Barkin J, Giddens J, Incze P et al (2012) UroLift system for relief of prostate obstruction under local anesthesia. Can J Urol 19(2):6217–6222

    PubMed  Google Scholar 

  3. Woo HH, Chin PT, McNicholas TA et al (2011) Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int 108(1):82–88

    Article  PubMed  Google Scholar 

  4. Woo HH, Bolton DM, Laborde E et al (2012) Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Sex Med 9(2):568–575

    Article  PubMed  Google Scholar 

  5. Chin PT, Bolton DM, Jack G et al (2012) Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 79(1):5–11

    Article  PubMed  Google Scholar 

  6. Arenas da Silva LF, Schönthaler M, Cruz F et al (2012) New treatment strategies for male lower urinary tract symptoms. Urologe A 51(12):1697–702

    Article  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Berges.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berges, R., Sievert, K., Gratzke, C. et al. UroLift®. Urologe 52, 350–353 (2013). https://doi.org/10.1007/s00120-012-3090-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-012-3090-4

Schlüsselwörter

Keywords

Navigation